Beam Therapeutics Inc. (BEAM) /
The revenue of Beam Therapeutics Inc. over the past 7 years
Chart Beam Therapeutics Inc.: revenue, fiscal 2019–2025 Open the chart →Beam Therapeutics Inc. reported revenue of $139.74M in fiscal 2025, the latest fiscal year on file. In fiscal 2019 it was $18K — up 776250% over 6 years. Year over year, revenue rose 5 times and fell once. In these years the highest was $377.71M in fiscal 2023. The largest one-year move was in fiscal 2021: up 215917%, from $24K to $51.84M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $139.74M |
| 2024ended Dec 31, 2024 | $63.52M |
| 2023ended Dec 31, 2023 | $377.71M |
| 2022ended Dec 31, 2022 | $60.92M |
| 2021ended Dec 31, 2021 | $51.84M |
| 2020ended Dec 31, 2020 | $24K |
| 2019ended Dec 31, 2019 | $18K |
Fiscal years as Beam Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Beam Therapeutics Inc.
- The profitability of Beam Therapeutics Inc.
- The cash flow of Beam Therapeutics Inc.
- The debt of Beam Therapeutics Inc.
- All of Beam Therapeutics Inc.'s financials, charted
Companies of a similar size
- CLSKCleanSpark, Inc.
- ADEAADEIA INC.
- QSQUANTUMSCAPE CORPORATION
- BHFBrighthouse Financial, Inc.
- UPSTUpstart Holdings, Inc.
Not investment advice. This page shows what Beam Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.